Mutations in the APC gene, a key negative regulator of the Wnt/β-catenin signalling pathway, are well-known drivers of tumorigenesis and have been increasingly reported in HCC (Xu et al., 2022; Bugter et al., 2021). The gene discussed is APC; the disease is hepatocellular carcinoma.